Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M HART

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Anales De Medicina Interna (Madrid, Spain : 1984)|December 17, 2002
[Cost-effectiveness analysis of Ramipril treatment of patients at high-risk of cardiovascular events in Spain]W M Hart, C Rubio-Terrés, I Margalet Fernández, et al.
Intensive Care Medicine|January 1, 1997
A cost analysis of a treatment policy of a deliberate perioperative increase in oxygen delivery in high risk surgical patientsJ F Guest, O Boyd, W M Hart, et al.
Investigative Ophthalmology & Visual Science|February 1, 1990
Glaucomatous visual field damage. Luminance and color-contrast sensitivitiesW M Hart, S E Silverman, G L Trick, et al.
Medicina Clinica|January 29, 2000
[Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain]M Boada, J Peña-Casanova, F Bermejo, et al.
Lipids|February 1, 1979
The metabolism of dihomo-gamma-linolenic acid in manK J Stone, A L Willis, W M Hart, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1989
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trialM A Kass, M O Gordon, M R Hoff, et al.
Journal of Glaucoma|November 19, 2009
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1)M A Kass, M O Gordon, M R Hoff, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
A cost evaluation of treatment alternatives for mild-to-moderate bleeding episodes in patients with haemophilia and inhibitors in BrazilM C Ozelo, P R Villaça, J O S C De Almeida, et al.
Clinical and Diagnostic Laboratory Immunology|January 5, 1999
Immune determinants of organism and outcome in febrile hospitalized Thai patients with bloodstream infectionsJ Jason, L Archibald, L C McDonald, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Anales De Medicina Interna (Madrid, Spain : 1984)|December 17, 2002
[Cost-effectiveness analysis of Ramipril treatment of patients at high-risk of cardiovascular events in Spain]W M Hart, C Rubio-Terrés, I Margalet Fernández, et al.
Intensive Care Medicine|January 1, 1997
A cost analysis of a treatment policy of a deliberate perioperative increase in oxygen delivery in high risk surgical patientsJ F Guest, O Boyd, W M Hart, et al.
Investigative Ophthalmology & Visual Science|February 1, 1990
Glaucomatous visual field damage. Luminance and color-contrast sensitivitiesW M Hart, S E Silverman, G L Trick, et al.
Medicina Clinica|January 29, 2000
[Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain]M Boada, J Peña-Casanova, F Bermejo, et al.
Lipids|February 1, 1979
The metabolism of dihomo-gamma-linolenic acid in manK J Stone, A L Willis, W M Hart, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1989
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trialM A Kass, M O Gordon, M R Hoff, et al.
Journal of Glaucoma|November 19, 2009
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1)M A Kass, M O Gordon, M R Hoff, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
A cost evaluation of treatment alternatives for mild-to-moderate bleeding episodes in patients with haemophilia and inhibitors in BrazilM C Ozelo, P R Villaça, J O S C De Almeida, et al.
Clinical and Diagnostic Laboratory Immunology|January 5, 1999
Immune determinants of organism and outcome in febrile hospitalized Thai patients with bloodstream infectionsJ Jason, L Archibald, L C McDonald, et al.
Pageof 5